A registrational trial of CS5001
Latest Information Update: 27 Aug 2024
At a glance
- Drugs LCB 71 (Primary)
- Indications Cancer
- Focus Registrational; Therapeutic Use
- Sponsors CStone Pharmaceuticals
Most Recent Events
- 23 Aug 2024 According to Cstone media release, company plan to present updated clinical data at the American Society of Hematology (ASH) annual meeting later this year.
- 11 Jun 2024 New trial record
- 04 Jun 2024 According to Cstone media release, registration clinical study will be launched before the end of 2024.